Pages that link to "Q70957825"
Jump to navigation
Jump to search
The following pages link to Identification of specific binding sites for glucagon-like peptide-1 on the posterior lobe of the rat pituitary (Q70957825):
Displaying 27 items.
- In vitro metabolic stability of exendin-4: pharmacokinetics and identification of cleavage products (Q28543699) (← links)
- Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice (Q30531048) (← links)
- Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide (Q33538367) (← links)
- Secretin, glucagon, gastric inhibitory polypeptide, parathyroid hormone, and related peptides in the regulation of the hypothalamus- pituitary-adrenal axis. (Q33891639) (← links)
- Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1. (Q34492959) (← links)
- The gut and food intake: an update for surgeons. (Q34621785) (← links)
- Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives (Q34635520) (← links)
- Pharmacokinetic and Pharmacodynamic Modeling of Exendin-4 in Type 2 Diabetic Goto-Kakizaki Rats (Q34702329) (← links)
- The role of incretins in glucose homeostasis and diabetes treatment (Q34901533) (← links)
- Characterization and distribution of prolactin releasing peptide (PrRP) binding sites in the rat--evidence for a novel binding site subtype in cardiac and skeletal muscle. (Q35042183) (← links)
- Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats (Q35061438) (← links)
- Target-mediated pharmacokinetic and pharmacodynamic model of exendin-4 in rats, monkeys, and humans (Q35913076) (← links)
- Class II G protein-coupled receptors and their ligands in neuronal function and protection (Q36211439) (← links)
- Glucagon-like peptide 1 (GLP-1) and metabolic diseases (Q36309183) (← links)
- Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing (Q36906311) (← links)
- Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line (Q37379534) (← links)
- Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats (Q37429168) (← links)
- Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage (Q40035788) (← links)
- Central Administration of Glucagon-Like Peptide-1 Activates Hypothalamic Neuroendocrine Neurons in the Rat* (Q42445138) (← links)
- Interspecies modeling and prediction of human exenatide pharmacokinetics (Q42680392) (← links)
- Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus. (Q45711419) (← links)
- Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem (Q48794136) (← links)
- Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction. (Q53293095) (← links)
- Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety (Q58448604) (← links)
- Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjects (Q60674318) (← links)
- Specific calcitonin gene-related peptide binding sites present throughout rat intestine (Q73305021) (← links)
- Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat (Q74248446) (← links)